NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Cash from Operations (2010 - 2026)

NextPlat's (NXPL) quarterly Cash from Operations came in at $1.1 million in Q2 2026, up 204.03% year-over-year from $356209.5 in Q2 2025, and up 141.93% quarter-over-quarter from -$2.6 million in Q1 2026.

Analysis

NextPlat (NXPL) Cash from Operations (2010 - 2026) Analysis & Trends

NextPlat (NXPL) has reported Cash from Operations for 15 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash from Operations rose 204.03% year-over-year to $1.1 million in Q2 2026; TTM through Jun 2026 was -$4.5 million, a 44.65% increase from a year earlier, with the FY2025 full-year figure at -$6.1 million, down 12.19% from the prior year.
  • Cash from Operations was $1.1 million for Q2 2026 at NextPlat, up from -$2.6 million in the prior quarter.
  • Over five years, Cash from Operations peaked at $2.3 million in Q2 2024 and troughed at -$4.6 million in Q3 2024.
  • A 5-year average of -$1.1 million and a median of -$983347.0 in 2022 frame the typical range for Cash from Operations.
  • The widest YoY moves for Cash from Operations: up 287.02% in 2024, down 386.69% in 2024.
  • Over 5 years, Cash from Operations stood at -$870924.0 in 2022, then surged by 174.75% to $651000.0 in 2023, then slumped by 173.12% to -$476000.0 in 2024, then soared by 36.55% to -$302000.0 in 2025, then soared by 458.61% to $1.1 million in 2026.
  • The last three Cash from Operations figures came in at $1.1 million (Q2 2026), -$2.6 million (Q1 2026), and -$302000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 411.00 Mn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 381.80 Mn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn -9.79 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn -21.24 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 670.00 Mn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 56.67 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn -19.79 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 51.32 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn -
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn 1.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.08 Mn
Mar 31, 2026 -2.58 Mn
Dec 31, 2025 -302,000.00
Sep 30, 2025 -2.73 Mn
Jun 30, 2025 -1.04 Mn
Mar 31, 2025 -2.06 Mn
Dec 31, 2024 -476,000.00
Sep 30, 2024 -4.61 Mn
Jun 30, 2024 2.31 Mn
Mar 31, 2024 -2.69 Mn
Dec 31, 2023 651,000.00
Sep 30, 2023 -947,000.00
Jun 30, 2023 -1.23 Mn
Mar 31, 2023 -2.07 Mn
Dec 31, 2022 -870,924.00
Sep 30, 2022 -842,824.00
Jun 30, 2022 -1.02 Mn
Mar 31, 2022 -868,558.00
Dec 31, 2021 -1.09 Mn
Sep 30, 2021 -1.73 Mn